AstraZeneca Zoladex Marketing Practices Under Investigation By DoJ
Executive Summary
A Department of Justice investigation into AstraZeneca's Zoladex marketing practices is continuing following the recent settlement with TAP over Lupron.
You may also be interested in...
AstraZeneca Nexium Marketing Draws FTC Scrutiny; DoJ Looking At Prilosec
The Federal Trade Commission is investigating AstraZeneca's marketing of the omeprazole follow-on product Nexium
AstraZeneca Nexium Marketing Draws FTC Scrutiny; DoJ Looking At Prilosec
The Federal Trade Commission is investigating AstraZeneca's marketing of the omeprazole follow-on product Nexium
AstraZeneca Self-Markets Nolvadex Generic; Zoladex Settlement Near
AstraZeneca is marketing its own generic version of Nolvadex (tamoxifen) to protect the company from claims that it is exploiting cancer patients in the final months of exclusivity for the drug